Tuesday, 26 March |
Date/Time |
Meetings/Events |
Room |
12.00 - 17.00 |
Registration opens (individuals, groups and exhibitors) |
Entrance hall |
|
Wednesday, 27 March |
Date/Time |
Meetings/Events |
Room |
07.00 - 17.00 |
Registration opens (individuals, groups and exhibitors) |
Entrance hall |
08.30 - 10.15 |
Opening ceremony & Keynote 1 - The OMICS approach - the buzz that makes the world go round !
ACPE UAN: 0475-0000-19-001-L04-P. A knowledge based activity.
G. Ecker*
|
Forum Auditorium |
10.15 |
Exhibition opens |
Area 1+2+3 |
10.15 - 11.45 |
Coffee break |
Area 1+2+3 |
10.30 - 12.00 |
Award nominee oral presentations |
116 |
|
Section 2: Selection, Procurement and Distribution
10:30 NETWORK META-ANALYSIS OF FIRST-LINE ANTIANGIOGENIC DRUGS IN ADVANCED RENAL CELL CARCINOMA M. D. Gil-Sierra
Section 3: Production and Compounding
10:38 HOT-MELT RAM EXTRUSION 3D PRINTING: A SMART METHOD FOR COMPOUNDING ORODISPERSIBLE FILMS IN HOSPITAL PHARMACIES U. M. Musazzi
Section 4: Clinical Pharmacy Services
10:46 ENCOURAGING THE RESPONSIBLE USE OF ANTIBIOTICS: AWARENESS AND UNDERSTANDING AMONG A UNIVERSITY STUDENT POPULATION OF A COMMUNITY PHARMACY PUBLIC HEALTH CAMPAIGN IN SCOTLAND A. Tonna
10:54 CHEMOTHERAPY NEAR THE END OF LIFE IN ONCO-HAEMATOLOGICAL ADULT PATIENTS E. Gómez de Salazar López de Silanes
11:02 IMPACT OF PHARMACEUTICAL INTERVIEW IN PATIENT ACCEPTANCE OF INSULIN GLARGINE’S BIOSIMILAR 100UI/ML M. Malassigné
11:10 DETERMINING THE NECESSARY COMPONENTS OF A PHARMACEUTICAL CARE COMPLEXITY SCREENING TOOL: AN E-DELPHI STUDY M. Alshakrah
11:18 A SYSTEMATIC REVIEW OF PHARMACIST INPUT IN THE SCREENING, MANAGEMENT AND PREVENTION OF METABOLIC SYNDROME A. Tonna
Section 5: Patient Safety and Quality Assurance
11:26 DRUG-DRUG INTERACTIONS IN PATIENTS WITH CARDIOVASCULAR DISEASES S. Biagini
11:34 SWITCHING FROM INDIVIDUALISED NUTRITION TO STANDARDISED OR COMMERCIALISED NUTRITION IN NEWBORNS: ARE THERE ANY POSSIBILITIES? Y-E. Nisse
11:42 TOXICITY WITH 5-FLUOROURACIL AND IRINOTECAN: INTEREST OF GENOTYPING IN PATIENT CARE M. Gallard
Section 6: Education and Research
11:50 A PILOT RANDOMISED DOUBLE-BLINDED PLACEBO-CONTROLLED TRIAL OF PROPHYLACTIC SILDENAFIL IN PRETERM INFANTS AT RISK OF BRONCHOPULMONARY DYSPLASIA D. Abushanab
|
|
10.30 - 11.45 |
Good Practice Initiative oral presentations |
115 |
|
Section 2: Selection, Procurement and Distribution
10:30 EXCESSIVE REORDERS: A CONTEST REDUCES WORKLOAD K. Mikula
Section 3: Production and Compounding
10:38 DEVELOPMENT OF NEW PRODUCTION WHEN NEITHER PACKAGING NOR SOME OF THE RAW MATERIALS CONFORM TO EUROPEAN STANDARDS K. B. Rubach-Larsen
10:46 HOW TO HANDLE ACTIVE AND PLACEBO DRUGS FOR A CLINICAL TRIAL IN THE PRODUCTION SYSTEM CATO IN ORDER TO SECURE THE BLIND AND TO ENSURE THE EXACT SAME PREPARATION OF ACTIVE AND PLACEBO PRODUCTS K. L. Vorbeck
Section 4: Clinical Pharmacy Services
10:54 IMPROVING THE CONTINUITY OF CARE IN CASE OF EXTRATEMPORANEOUS MEDICINES FOR CHILDREN S. Sauer
11:02 USING AN ELECTRONIC ALGORITHM TO IDENTIFY THE MOST RELEVANT PATIENTS FOR MEDICATION REVIEW C. Olesen
|
|
10.45 - 11.15 |
Bayer - "Meet the expert" session |
|
|
Rivaroxaban: Tailored Protection for Your CardioVascular Patients
Expanding Clinical Evidence to CAD and PAD
L. Agati
|
Bayer - Stand 19
Exhibiiton Area
|
12.00 - 13.30 |
Synergy Satellite Event |
|
|
Biosimilars – available yet sometimes missing – the challenge of procurement (sponsored by an educational grant from Amgen)
ACPE UAN: 0475-0000-19-004-L04-P. A knowledge based activity.
I. Huys; J. Kent; A. Alcobia.
|
Forum Auditorium |
13.30 - 14.45 |
Lunch |
Area 1+2+3 |
13.45 - 14.15 |
Bayer - "Meet the expert" session |
|
|
Rivaroxaban: Tailored Protection for Your CardioVascular Patients
Translating Clinical Evidence Into Practice
L. Van der Linden
|
Bayer - Stand 19
Exhibiiton Area
|
14.45 - 16.45 |
Student Programme - How can hospital pharmacists implement antimicrobial stewardship to ensure rational use of antimicrobials?
ACPE UAN: 0475-0000-19-031-L01-P. An application based activity.
A.Tonna; T. Hoppe-Tichy
|
124 |
14.45 - 16.15 |
Synergy Interactive Event |
|
|
Anticoagulation – improving efficacy and preventing side effects (sponsored by an educational grant from Bayer)
ACPE UAN: 0475-0000-19-005-L01-P. An application based activity.
L. Van der Linden*; C. Quintens.
|
116 |
14.45 - 16.15 |
Seminars |
|
|
Seminar IG1 - Implementation science - the inside story
ACPE UAN: 0475-0000-19-009-L01-P. A knowledge based activity.
M. Teichert*; L. Poulsen
|
113 |
|
Seminar SPD2 - Managed entry agreements - risk sharing and beyond
ACPE UAN: 0475-0000-19-013-L04-P. A knowledge based activity.
S. Brown; C. Ferri
|
115 |
|
Seminar SPD1 - Health technology assessment - one step further!
ACPE UAN: 0475-0000-19-012-L04-P. A knowledge based activity.
J. Perelman; M-J. Lamas
|
117 |
|
Seminar PC1 - Individual preparations - time to change the law?
ACPE UAN: 0475-0000-19-016-L07-P. A knowledge based activity.
H. Scheepers; P. Le Brun
|
211 |
|
Interactive Session 1 - The role of pharmacogenomics in medication optimisation
ACPE UAN: 0475-0000-19-023-L01-P. A knowledge based activity.
R. Turner; B. Sproule
|
125 |
14.45 - 16.15 |
Industry Sponsored Satellites |
|
|
MSD
"Shifting Paradigms For Critically Ill Patients With Gram-Negative Infections: Redefining Treatment Strategies"
|
111 |
|
Accord Healthcare
“Biosimilars - Improving Access and Optimising Practice”
|
114 |
16.15 - 17.00 |
Coffee break |
Area 1+2+3 |
17.00 - 18.30 |
Synergy Satellite Event |
|
|
Biosimilars - challenging misconceptions, optimising uptake, maximising value (financial support was provided by Pfizer Limited as a Medical and Educational Goods and Service)
ACPE UAN: 0475-0000-19-006-L04-P. A knowledge based activity.
M. Flume*; A. McWhirter.
|
116 |
17.00 - 18.30 |
Seminars |
|
|
Seminar CPS1 - Responding to individual metabolism by genomics and metabolomics
ACPE UAN: 0475-0000-19-020-L04-P. A knowledge based activity.
C. Nievergelt; S. J. Krähenbühl
|
113 |
|
Seminar PC2 - Preparation for neonates - a sensitive population
ACPE UAN: 0475-0000-19-017-L07-P. A knowledge based activity.
M. Paulsson*; I. Sviestina
|
114 |
|
Seminar PC3 - From gene therapy to cell therapy - what about hospital pharmacy?
ACPE UAN: 0475-0000-19-018-L01-P. A knowledge based activity.
T. Hoppe-Tichy*; N. A. A. de Miranda
|
115 |
|
Seminar ER2 - European Hospital Pharmacists - the future in the making (this session will run once only)
ACPE UAN: 0475-0000-19-029-L04-P. A knowledge based activity.
R. Frontini*; S. Kohl; E. Fernandez de Gamarra; C. Plesan
|
117 |
|
Seminar PC4 - Radiopharmacy - does it glow in the dark?
ACPE UAN: 0475-0000-19-019-L04-P. A knowledge based activity.
E-M. Klebermass, G. Bormans
|
125 |
|
Seminar PQ1 - Drug-related hospital admissions - detection and prevention
ACPE UAN: 0475-0000-19-024-L04-P. A knowledge based activity.
O. Dalleur; S. Thevelin; E. Uitvlugt
|
211 |
|
Workshop 4 - Pharmacist-patient relationship in clinical trials
ACPE UAN: 0475-0000-19-030-L03-P. An application based activity.
B. Brignolo Ottolini; S. V. Rossi
Handouts
|
124 |
|
Workshop 2 - To make or to buy?
ACPE UAN: 0475-0000-19-015-L07-P. An application based activity.
D. Devolder; T. Storme*
Handouts
|
127 |
17.00 - 18.30 |
Industry Sponsored Satellites |
|
|
Roche
"Supressing now progression in Multiple Sclerosis"
|
111 |
18.30 - 20.00 |
Get together reception |
Area 1+2+3 |
19.00 - 20.00 |
Poster walk - Join the Scientific Committee during their evaluation of the posters selected for the Poster Walk |
Area 3 |
20.00 |
Exhibition closes |
|
|
Thursday, 28 March |
Date/Time |
Meetings/Events |
Room |
06.30 - 17.00 |
Registration opens (individuals, groups and exhibitors) |
Entrance hall |
07.00 - 08.30 |
Synergy Satellite Event |
|
|
Facing Brexit and FMD - Is Europe ready for the double "storm"? (this session will run once only)
ACPE UAN: 0475-0000-19-008-L04-P. A knowledge based activity.
S. Kohl; A. Mathieu-Mendes; M. Dias.
|
211 |
08.30 - 18.00 |
Exhibition opens
|
Area 1+2+3 |
08.45 - 10.15 |
Synergy Interactive Event |
|
|
Anticoagulation – improving efficacy and preventing side effects (sponsored by an educational grant from Bayer)
ACPE UAN: 0475-0000-19-005-L01-P. An application based activity.
L. Van der Linden*; C. Quintens.
|
116 |
08.45 - 10.15 |
Seminars |
|
|
Seminar IG1 - Implementation science - the inside story
ACPE UAN: 0475-0000-19-009-L01-P. A knowledge based activity.
M. Teichert*, L. Poulsen
|
113 |
|
Seminar PC2 - Preparation for neonates - a sensitive population
ACPE UAN: 0475-0000-19-017-L07-P. A knowledge based activity.
M. Paulsson*; I. Sviestina
|
114 |
|
Seminar CPS3 - Optimising medication adherence
ACPE UAN: 0475-0000-19-022-L01-P. A knowledge based activity.
M. Airaksinen; U. Hedegaard
|
115 |
|
Seminar SPD1 - Health technology assessment - one step further!
ACPE UAN: 0475-0000-19-012-L04-P. A knowledge based activity.
J. Perelman; M. J. Alcaraz
|
117 |
|
Seminar ER1 - When numbers are small - clinical trials in rare diseases
ACPE UAN: 0475-0000-19-028-L04-P. A knowledge based activity.
A. Addis; F. Houÿez
|
211 |
|
Workshop 4 - Pharmacist-patient relationship in clinical trials
ACPE UAN: 0475-0000-19-030-L03-P. An application based activity.
B. Brignolo Ottolini ; S. V. Rossi
Handouts
|
124 |
|
Interactive Session 1 - The role of pharmacogenomics in medication optimisation
ACPE UAN: 0475-0000-19-023-L01-P. A knowledge based activity.
R. Turner; B. Sproule
|
125 |
08.45 - 10.15 |
Industry Sponsored Satellites |
|
|
ICU MEDICAL
"Hazardous Drug Safety - An Update on Guidelines, CSTD Compliance Test and What to Consider with a CSTD"
|
111 |
|
FRESENIUS KABI
"The pharmacist's role in meeting the needs of every parenteral nutrition patient"
|
112 |
10.15 - 11.15 |
Coffee break and attended posters Have a cup of coffee with the authors and see the latest research from your peers!
|
Area 1+2+3 |
11.15 - 12.15 |
Keynote 2 - Clinical human factors - delivering healthcare under pressure
ACPE UAN: 0475-0000-19-002-L04-P. A knowledge based activity.
J. Carthey
|
Forum Auditorium |
12.15 - 13.30 |
Lunch |
Area 1+2+3 |
12.20 - 12.50 |
Bayer - "Meet the expert" session |
|
|
Rivaroxaban: Tailored Protection for Your CardioVascular Patients
Expanding Clinical Evidence to CAD and PAD
L. Agati
|
Bayer - Stand 19
Exhibition area
|
12.50 - 13.20 |
Bayer - "Meet the expert" session |
|
|
Rivaroxaban: Tailored Protection for Your CardioVascular Patients
Translating Clinical Evidence Into Practice
L. Van der Linden
|
Bayer - Stand 19
Exhibition area
|
13.30 - 15.00 |
Synergy Satellite Event |
|
|
Biosimilars - challenging misconceptions, optimising uptake, maximising value (financial support was provided by Pfizer Limited as a Medical and Educational Goods and Service)
ACPE UAN: 0475-0000-19-006-L04-P. A knowledge based activity.
M. Flume*; A. McWhirter.
|
116 |
13.30 - 15.00 |
Seminars |
|
|
Seminar CPS1 - Responding to individual metabolism by genomics and metabolomics
ACPE UAN: 0475-0000-19-020-L04-P. A knowledge based activity.
C. Nievergelt; S. J. Krähenbühl
|
113 |
|
Seminar PQ3 - Social media and pharmacovigilance 2.0
ACPE UAN: 0475-0000-19-026-L04-P. A knowledge based activity.
A-M. de Ferran; U. Moretti
|
114 |
|
Seminar PC3 - From gene therapy to cell therapy - what about hospital pharmacy?
ACPE UAN: 0475-0000-19-018-L01-P. A knowledge based activity.
T. Hoppe-Tichy*; N. A. A. de Miranda
|
115 |
|
Seminar PQ2 - High-alert medicines and risk minimisation of medication errors (this session will run once)
ACPE UAN: 0475-0000-19-025-L04-P. A knowledge based activity.
O. Lapatto-Reiniluoto; Y. Jani
|
117 |
|
Seminar PC4 - Radiopharmacy - does it glow in the dark?
ACPE UAN: 0475-0000-19-019-L04-P. A knowledge based activity.
E-M. Klebermass; G. Bormans
|
125 |
|
Seminar PC1 - Individual preparations - time to change the law?
ACPE UAN: 0475-0000-19-016-L07-P. A knowledge based activity.
H. Scheepers; P. Le Brun
|
211 |
|
Workshop 2 - To make or to buy?
ACPE UAN: 0475-0000-19-015-L07-P. An application based activity.
D. Devolder; T. Storme*
Handouts
|
127 |
13.30 - 15.00 |
Industry Sponsored Satellites |
|
|
AMGEN
"Upholding quality patient care with biosimilars"
|
111 |
15.00 - 15.45 |
Coffee break |
Area 1+2+3 |
15.45 - 17.15 |
Synergy Satellite Event |
|
|
Biosimilars in haemato-oncology - new blood, old questions (sponsored by an educational grant from SANDOZ)
ACPE UAN: 0475-0000-19-007-L01-P. A knowledge based activity.
B. Klindt Poulsen; N. A. A. de Miranda; A. Gouveia.
|
116 |
15.45 - 17.15 |
Seminars |
|
|
Seminar CPS2 - Medicines optimisation in paediatric patients
ACPE UAN: 0475-0000-19-021-L04-P. A knowledge based activity.
B. Deleenheer; K. Hämeen-Anttila
|
113 |
|
Seminar SPD3 - Inaccessibility of the right drugs
ACPE UAN: 0475-0000-19-014-L04-P. A knowledge based activity.
A. Sieg; S. Luterbacher
|
114 |
|
Seminar SPD2 - Managed entry agreements - risk sharing and beyond
ACPE UAN: 0475-0000-19-013-L04-P. A knowledge based activity.
S. Brown; C. Ferri
|
115 |
|
Seminar IG2 - May I please speak with my hospital pharmacist? (this session will run once)
ACPE UAN: 0475-0000-19-010-L04-P. A knowledge based activity.
K. Ocko; C. Fonzo-Christe; C. Hynes
|
117 |
|
Seminar PQ1 - Drug-related hospital admissions - detection and prevention
ACPE UAN: 0475-0000-19-024-L04-P. A knowledge based activity.
O. Dalleur; S. Thevelin; E. Uitvlugt
|
211 |
|
Workshop 3 - Learning from medication errors
ACPE UAN: 0475-0000-19-027-L04-P. An application based activity.
Y. Jani; C. Linden-Lahti
Handouts
|
124 |
|
Workshop 1 - Human factors in practice
ACPE UAN: 0475-0000-19-011-L04-P. An application based activity.
J. Carthey
Handouts
|
127 |
15.45 - 17.15 |
Industry Sponsored Satellites |
|
|
B. BRAUN Melsungen AG
"IV Ibuprofen – A new option in multimodal analgesia"
|
111 |
18.00 |
Exhibition closes
|
|
|
|
Friday, 29 March |
|
Date/Time |
Meetings/Events |
Room |
07.00 - 08.00 |
EAHP Fun Run: Explore Barcelona running! Bring your running shoes!
A 5 km run through highlights of Barcelona to support children with cancer (Children's Cancer Netherlands (KiKa))
|
Entrance of the CCIB |
08.00 - 11.00 |
Registration opens (individuals, groups and exhibitors) |
Entrance hall |
09.00 |
Exhibition opens |
Area 1+2+3 |
09.00 - 10.30 |
Synergy Satellite Event |
|
|
Biosimilars in haemato-oncology - new blood, old questions (sponsored by an educational grant from SANDOZ)
ACPE UAN: 0475-0000-19-007-L01-P. A knowledge based activity.
B. Klindt Poulsen; N. A. A. de Miranda; A. Gouveia.
|
116 |
09.00 - 10.30 |
Seminars |
|
|
Seminar ER1 - When numbers are small - clinical trials in rare diseases
ACPE UAN: 0475-0000-19-028-L04-P. A knowledge based activity.
A. Addis; F. Houÿez
|
111 |
|
Seminar PQ3 - Social media and pharmacovigilance 2.0
ACPE UAN: 0475-0000-19-026-L04-P. A knowledge based activity.
A-M. de Ferran; U. Moretti
|
112 |
|
Seminar CPS2 - Medicines optimisation in paediatric patients
ACPE UAN: 0475-0000-19-021-L04-P. A knowledge based activity.
B. Deleenheer; K. Hämeen-Anttila
|
113 |
|
Seminar SPD3 - Inaccessibility of the right drugs
ACPE UAN: 0475-0000-19-014-L04-P. A knowledge based activity.
A. Sieg; S. Luterbacher |
114 |
|
Seminar CPS3 - Optimising medication adherence
ACPE UAN: 0475-0000-19-022-L01-P. A knowledge based activity.
M. Airaksinen; U. Hedegaard
|
115 |
|
Workshop 3 - Learning from medication errors
ACPE UAN: 0475-0000-19-027-L04-P. An application based activity.
Y. Jani; C. Linden-Lahti
Handouts
|
124 |
|
Workshop 1 - Human factors in practice
ACPE UAN: 0475-0000-19-011-L04-P. An application based activity.
J. Carthey
Handouts
|
125 |
10.30 - 11.30 |
Coffee break and attended posters Have a cup of coffee with the authors and see the latest research from your peers! |
Area 1+2+3 |
11.30 - 13.00 |
Closing ceremony & Keynote 3 - Inequalities in European health systems - economics versus access
ACPE UAN: 0475-0000-19-003-L04-P. A knowledge based activity.
R. Busse
|
Forum Auditorium |
12.00 |
Exhibition closes |
|